Treatment of hemophilic arthropathy by immunomodulatory extracellular vesicle delivered by liposome hybrid nanoparticles
In individuals afflicted with hemophilia, characterized by a deficiency of coagulation FRESH PLUS factor VIII (FVIII), the occurrence of spontaneous recurrent intra-articular hemorrhage precipitates the emergence of hemophilic arthropathy (HA).Although clotting factor replacement therapy reduces joint bleeding clinically, clotting factors need to b